HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Bolletta Selected Research

Natural Cytotoxicity Triggering Receptor 3

1/2021Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Bolletta Research Topics

Disease

1Ocular Tuberculosis
08/2022
1Sarcoidosis (Schaumann Disease)
08/2022
1Uveitis
08/2022
1Behcet Syndrome (Behcet's Syndrome)
01/2021
1Macular Edema
01/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2017
1Macular Degeneration (Age-Related Maculopathy)
01/2017
1Retinal Diseases
01/2017
1Basal Cell Nevus Syndrome (Gorlin Syndrome)
12/2016
1Wounds and Injuries (Trauma)
09/2015
1Infections
09/2015

Drug/Important Bio-Agent (IBA)

1GoldIBA
08/2022
1CytokinesIBA
08/2022
1Natural Cytotoxicity Triggering Receptor 1IBA
01/2021
1Natural Cytotoxicity Triggering Receptor 3IBA
01/2021
1InterferonsIBA
01/2020
1Retinaldehyde (Retinal)IBA
01/2017
1Metalloproteases (Metalloproteinases)IBA
09/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2015

Therapy/Procedure

2Therapeutics
01/2017 - 09/2015
1Injections
01/2020
1Perforator Flap
12/2016